Verge Genomics
ID: 5301262Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
5
Funding Rounds
$134.1m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ch** |
|
- | linkedin twitter |
| Al*** Zh*** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Verge Genomics has raised a total of $102.12m in funding over 5 rounds.
Key Insights:
- Verge Genomics Series B round, December 16, 2021: $98m
- Verge Genomics Seed round, October 29, 2015: $4m
- Verge Genomics Seed round, August 18, 2015: $120k
- Verge Genomics funding round, July 2018: $32m
Industries
Verge Genomics is active in the following industries: